Veris Health, a wholly-owned subsidiary of New York’s PAVmed Inc., is a digital health company that has developed a digital cancer care platform with physiologic data collection, symptom reporting, and telehealth functions. The Veris CPP is meant to improve personalized cancer care through remote patient monitoring.
Besides traditional Bluetooth-enabled physiologic sensors, Veris has been developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris cancer care remote patient monitoring platform.
This is the first time I see this interesting concept, so I wanted to bring it to the attention of my readers although I haven’t found details on the implant besides a presentation at LSI USA ‘23 Emerging Medtech Summit by its Chairman and CEO, Dr. Lishan Aklog.